NasdaqGS:GEHCMedical Equipment
FDA and CE Clearance of Allia Moveo Might Change The Case For Investing In GE HealthCare (GEHC)
In late January 2026, GE HealthCare announced that its Allia Moveo interventional imaging system received U.S. FDA 510(k) clearance and CE Marking, enabling broader clinical use across cardiovascular, vascular, non-vascular, and surgical procedures.
The cable-free, AI-enabled Allia Moveo platform is designed to tackle space, workflow, and noise constraints in interventional suites, reflecting GE HealthCare’s focus on integrating advanced imaging with practical, clinician-informed...